Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Sidney B Radomski"'
Autor:
Rano Matta, Erind Dvorani, Christopher Wallis, Amanda Hird, Joseph LaBossiere, Girish Kulkarni, Ronald Kodama, Lesley Carr, Sidney B Radomski, Refik Saskin, Sender Herschorn, Robert K Nam
Publikováno v:
BMJ Open, Vol 9, Iss 12 (2019)
Objectives To examine the complication rates after benign prostatic enlargement (BPE) surgery and the effects of age, comorbidity and preoperative medical therapy.Design A retrospective, population-based cohort study using linked administrative data.
Externí odkaz:
https://doaj.org/article/c27ba983ca1c4062b1e180086969e6f1
Publikováno v:
Neurourology and Urodynamics. 41:1764-1769
The artificial urinary sphincter (AUS) is the gold standard for males with urinary incontinence. It is generally a safe procedure with a high degree of satisfaction. However, there is a lifelong risk of infection and erosion. AUS cuffs are commonly p
Autor:
Rano Matta, Ronald T. Kodama, Refik Saskin, Sender Herschorn, Amanda Hird, Robert K. Nam, Sidney B. Radomski, Lesley K. Carr
Publikováno v:
Journal of Urology. 203:591-597
Purpose:Previous studies have shown an association between urinary incontinence and increased mortality independently of demographics and health status. However, they do not account for the effect ...
Autor:
Tariq F. Al-Shaiji, Sidney B. Radomski
Publikováno v:
International Neurourology Journal, Vol 16, Iss 3, Pp 126-131 (2012)
Purpose Overactive bladder (OAB) is a common condition. In women, studies have shown that the prevalence of OAB is positively related to increasing body mass index (BMI). Our objective was to define a relationship between BMI and OAB through correlat
Externí odkaz:
https://doaj.org/article/cc0a9b5a9bb54b0699d2d4b7912ac391
Autor:
Sidney B. Radomski, Mai Banakhar, Malak Abuzgaya, Magdy Hassouna, Abdullah Ghazi, Ali Alabbad, Dean Elterman
Publikováno v:
Journal of King Abdulaziz University - Medical Sciences. 26:11-18
The aim of our study was to determine the effect of preoperative urodynamic reading of valsalva leak point pressure on the result of mid-urethral sling surgery. From January 2010 to December 2014, a total of 207 patients underwent mid-urethral sling
Publikováno v:
Journal of Urology. 200:1093-1098
The artificial urinary sphincter is a common treatment of male urinary incontinence. We sought to characterize long-term rates of artificial urinary sphincter revision/removal and reimplantation, and associated risk factors.We performed a population
Publikováno v:
Neurourology and Urodynamics. 37:2810-2817
AIMS To determine the effectiveness of mirabegron in patients with neurogenic lower urinary tract dysfunction. METHODS Randomized, double-blind, placebo-controlled study. Canadian patients with spinal cord injury (SCI) or multiple sclerosis (MS) with
Autor:
Christopher J.D. Wallis, Joseph LaBossiere, Erind Dvorani, Girish Kulkarni, Lesley K. Carr, Ronald T. Kodama, Robert K. Nam, Refik Saskin, Rano Matta, Sender Herschorn, Sidney B. Radomski, Amanda Hird
Publikováno v:
BMJ Open
ObjectivesTo examine the complication rates after benign prostatic enlargement (BPE) surgery and the effects of age, comorbidity and preoperative medical therapy.DesignA retrospective, population-based cohort study using linked administrative data.Se
Autor:
Lesley K. Carr, Rano Matta, Sender Herschorn, Robert K. Nam, Ronald T. Kodama, Humberto R. Vigil, Christopher J.D. Wallis, Armando J. Lorenzo, Sidney B. Radomski
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:Patients with neuropathic bladder dysfunction associated with spina bifida are typically diagnosed and initially treated by pediatric specialists. Abrupt transition of c...
Autor:
Sidney B. Radomski, David A. Ginsberg, Rafael Wurzel, Christopher R. Chapple, Dirk De Ridder, Victor W. Nitti, David Sussman, Andrew Magyar, Brenda Jenkins, Peter K. Sand, Karl-Dietrich Sievert
Publikováno v:
Journal of Urology. 196:791-800
These are the final results of the prospective, multicenter, long-term (3.5-year) study of the efficacy/safety of onabotulinumtoxinA for overactive bladder syndrome.Patients who completed either of 2, 24-week phase 3 trials could enter a 3-year exten